JPRN-UMIN000023487已完成未知
Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY) - Study of the beneficial effect of Canagliflozin on nocturnal home BP in Japanese T2DM patients(SHIFT-J STUDY)
Jichi Medical University School of Medicine0 个研究点目标入组 100 人开始时间: 2016年8月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(Exclusion Criteria) (1) Taking SGLT2 inhibitors (2) Prescribed insulin (3) Taking diuretics (4) Prescribed GLP-1 receptor agonists (5) History of hypersensitivity due to SGLT2 inhibitors (6) History of cerebral infarction (7) Advanced renal dysfunction or end-stage renal failure and undergoing dialysis (8) Pregnant or possibility of pregnancy (9) Breastfeeding (10) Participating in another clinical study or trial (excluding observational studies) (11) Deemed ineligible for another reason by the study doctor (Exclusion Criteria for Enrollment) (1) Deemed difficult to continue in the study by the study doctor during observation due to home blood pressure measurement state (2) Severe adverse event observed during observation period (3) Deemed ineligible for another reason during the observation period by the study doctor
研究者
相似试验
尚未招募
不适用
Effect of canagliflozin as an alternative drug from DPP-4 inhibitor on heart failure with diabetis melltus : the pilot study "Can canagliflozin HAve Not only hypoGlycemic but cardiac supportive Effect?"chronic heart failure with type 2 diabetis mellitusJPRN-UMIN000031563Osaka Rosai Hospital40
进行中（未招募）
1 期
The effect of canagliflozin 300mg on glucose levels in people without diabetes after weight loss surgery.EUCTR2019-004041-32-GBniversity of Leicester24
已完成
不适用
The effect of canagliflozin on the blood sugar levels of people without diabetes after weight loss surgeryHypoglycaemia after eating due to weight-loss surgerySurgeryISRCTN11342830niversity of Leicester36
招募中
不适用
The efficacy and safety of Canagliflozin for the treatment of NAFLD/NASH patients with type2 DMAFLD/NASHJPRN-UMIN000036560ippon Medical School Chiba Hokusoh Hospital Division of Gastroenterology30
已完成
4 期
A clinical trial to compare the effects of Canagliflozin and Sitagliptin in Patients with Type 2 Diabetes mellitus on a background metformin therapy.CTRI/2019/02/017435SRM College of Pharmacy40